PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3798308

A new total substitute urinary bladder.

C L Reynolds·J D Parkhurst
View original source ↗Export metadata ↓

Abstract

A surgical technique for the creation of an antireflux reservoir type substitute urinary bladder using the distal part of the ileum and aimed at meeting the demands expected of its normal counterpart is presented. Two male patients who underwent radical cystoprostatectomy with pelvic node dissection without urethrectomy for transitional cell carcinoma of the bladder are discussed herein. Variations in the creation of the reservoirs in both patients are described and the preliminary results reported.

Explore related subjects

Carcinoma, Transitional CellHumansIleumMaleMiddle AgedUrinary BladderUrinary Bladder NeoplasmsUrinary DiversionUrinationValsalva ManeuverJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C L Reynolds, J D Parkhurst. 1987. A new total substitute urinary bladder.. https://pubmed.ncbi.nlm.nih.gov/3798308/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Trimodality treatment and selective organ preservation for bladder cancer.

Standard treatment for muscle-invasive bladder cancer is cystectomy. Trimodality treatment, including transurethral resection of the bladder tumor (TURBT), radiation therapy and chemotherapy, has been shown to produce survival rates comparable to those of cystectomy. With these programs, cystectomy has been reserved for patients with incomplete response or local relapse. During the past 15 years, organ preservation by trimodality treatment has been investigated in prospective series from single centers and cooperative groups, with more than 1,000 patients included. Five-year overall survival rates in the range of 50% to 60% have been reported, and approximately three quarters of the surviving patients maintained their bladder. Clinical criteria helpful in determining ideal patients for bladder preservation include early tumor stage (including high-risk T1 disease), a visibly complete TURBT, and absence of ureteral obstruction. Close coordination among all disciplines is required to achieve optimal results. Future investigations will focus on (1) optimizing radiation techniques and incorporating more effective systemic chemotherapy, and (2) the proper selection of patients based on molecular makers.

Carcinoma, Transitional Cell↗